← Back to Search

Multisystemic Therapy for Emerging Adults for Antisocial Personality Disorder (MST-EA Trial)

N/A
Waitlist Available
Led By Maryann Davis, PhD
Research Sponsored by University of Massachusetts, Worcester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 months pre-baseline compared with 16 months post-baseline
Awards & highlights

MST-EA Trial Summary

This trial will test how well MST-EA works in reducing antisocial behavior in young adults with mental illness.

Eligible Conditions
  • Antisocial Personality Disorder

MST-EA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 months pre-baseline compared with 16 months post-baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 months pre-baseline compared with 16 months post-baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in number and severity of criminal charges in official records in the 16 months pre-baseline compared with the 16 months post-baseline.
Secondary outcome measures
Changes from Baseline scores compared to 16 months post-Baseline Antisocial Peers (measured at 0,2,4,6,8,12 and 16 months).
Changes from Baseline scores compared to 16 months post-Baseline Drug Screens (measured at 0,2,4,6,8,12 and 16 months).
Changes from Baseline scores compared to 16 months post-Baseline Goal directness (measured at 0,2,4,6,8,12 and 16 months).
+9 more

MST-EA Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Multisystemic Therapy - Emerging AdultsExperimental Treatment1 Intervention
Multisystemic Therapy for Emerging Adults (MST-EA) is designed to help emerging adults (ages 18-21) with mental illness who have been in trouble with the law. MST-EA is a treatment program specifically for emerging adults, to increase skills and capacities that can help them reduce their antisocial behavior and help reduce problems caused by mental health illness, and alcohol or drug use when present.
Group II: Enhanced Treatment as UsualActive Control1 Intervention
With Enhanced Treatment as Usual (E-TAU) emerging adults will get the treatments that they usually receive when they have a mental illness and have been in trouble with the law. They will receive travel vouchers for attending services, a card with an individualized list of contacts when in crisis, and facilitation with identifying need of services and accessing those services.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Multisystemic Therapy for Emerging Adults
2016
N/A
~200

Find a Location

Who is running the clinical trial?

Court Support Services DivisionUNKNOWN
1 Previous Clinical Trials
183 Total Patients Enrolled
1 Trials studying Antisocial Personality Disorder
183 Patients Enrolled for Antisocial Personality Disorder
Youth VillagesOTHER
2 Previous Clinical Trials
237 Total Patients Enrolled
1 Trials studying Antisocial Personality Disorder
183 Patients Enrolled for Antisocial Personality Disorder
University of Massachusetts, WorcesterLead Sponsor
342 Previous Clinical Trials
976,399 Total Patients Enrolled
1 Trials studying Antisocial Personality Disorder
183 Patients Enrolled for Antisocial Personality Disorder

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I meet the eligibility criteria to participate in this research?

"This clinical trial seeks 193 participants who are aged 16 to 26 and display antisocial behavior. Moreover, the prospective enrollees must be able to reside in a stable environment (not currently homeless or hospitalized) within 18 months of their most recent arrest that is not for parole/probation violations; furthermore, they may have issues with mood disorders, anxiety symptoms, or psychosis. Lastly, participant consent is required."

Answered by AI

Are there opportunities to join this clinical endeavor?

"The clinical trial registry on clinicialtrials.gov clarifies that this particular medical study is not currently enrolling participants, having been initially posted in September 2016 and last edited October 2022. Thankfully, 6 other trials are presently recruiting patients to join their programs."

Answered by AI

How many healthcare centers are actively participating in this research?

"Currently, 4 sites are hosting this clinical trial. Patients can select their closest location in Hamden, New Haven, Johnson City or one of the other locales to reduce transportation challenges when they enroll."

Answered by AI

Is the age requirement for participation in this trial restricted to individuals over 25?

"The requisite age range for this trial is 16-26 years old, stated in the study's entry criteria."

Answered by AI
~22 spots leftby Apr 2025